Acceptance and Commitment Therapy for Chemsex

NCT ID: NCT06980974

Last Updated: 2025-12-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2025-12-01

Study Completion Date

2030-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Quasi-randomized control trial of acceptance and commitment therapy (ACT) for chemsex.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Intervention will entail a prescreening, intake session, 16 therapy sessions, and a six-month follow-up. Each session will be 45-55 minutes long. Participants in ACT-for-chemsex will be compared to participants in a treatment as usual condition.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chemsex

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ACT-for-chemsex

16 weeks of ACT to reduce chemsex

Group Type EXPERIMENTAL

ACT-for-chemsex

Intervention Type BEHAVIORAL

16 weeks of acceptance and commitment therapy, delivered online weekly, 45-55 minute sessions

Treatment as usual

Treatment as usual

Group Type ACTIVE_COMPARATOR

Treatment as Usual (TAU)

Intervention Type OTHER

Participants in TAU will receive health/mental health interventions as needed

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ACT-for-chemsex

16 weeks of acceptance and commitment therapy, delivered online weekly, 45-55 minute sessions

Intervention Type BEHAVIORAL

Treatment as Usual (TAU)

Participants in TAU will receive health/mental health interventions as needed

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male
* age 18-65
* access to internet capable smart device
* documentation of Alabama residence
* access to a private area to attend tele ACT-for-chemsex sessions
* self-reported chemsex within six-months of intake
* English fluency.

Exclusion Criteria

* Psychotic disorder
* bipolar disorder
* eating disorder
* major neurocognitive disorder diagnosis
* self-harm or suicide attempt within 12 months of screener
* suicide plan/intention at time of screening
* ongoing treatment for a complex medical comorbidity (e.g., in patient cancer treatment)
* current enrollment in an individual ACT-based psychotherapy intervention.
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Alabama at Birmingham

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Nicholas C. Borgogna

Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Alabama at Birmingham

Birmingham, Alabama, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IRB-300014764

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Testing the Efficacy of ACT for Life
NCT04829682 ENROLLING_BY_INVITATION NA
A Brief Intervention
NCT01632176 COMPLETED NA